Here we review genetic modifiers of Aβ and Tau-based AD models,we restrict our discussion to three organisms in which large-scale screens have been accomplished, S. cerevisiae, C. elegans, and D. melanogaster. This evidence concerns the gene MAPT and Alzheimer disease.